TOTAL S.A.:企業のM&A・事業提携・投資動向

◆英語タイトル:TOTAL S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C0830
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:148
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

TOTAL S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s TOTAL S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by TOTAL S.A. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes TOTAL S.A.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by TOTAL S.A.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on TOTAL S.A.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by TOTAL S.A. and its subsidiaries since 2007.
- Information about key financial and legal advisors for TOTAL S.A.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about TOTAL S.A.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 69
Corporate Venturing – Overview 69
Corporate Venturing – Deal reports 70
PARTNERSHIP 78
Partnership – Overview 78
Partnership – Deal reports 79
CAPITAL RAISING 94
Capital Raising – Overview 94
Capital Raising – Deal reports 95
DIVESTMENTS 101
Divestments – Overview 101
Divestments – Deal reports 102
APPENDIX 138
Contact Us 138
About MarketLine Financial Deals Database 138
Deal Definition and Methodology 140
About MarketLine 147

List of Tables
Table 1: Total S.A. M&A volume and value trend (2014-YTD2018)
Table 2: Total S.A. M&A activity by geography (2014-YTD2018)
Table 3: Total S.A. corporate venturing volume and value trend (2014-YTD2018)
Table 4: Total S.A. corporate venturing by geography (2014-YTD2018)
Table 5: Total S.A. partnership volume and value trend (2014-YTD2018)
Table 6: Total S.A. partnership trend by key deal type (2014-YTD2018)
Table 7: Total S.A. capital raising volume and value trend (2014-YTD2018)
Table 8: Total S.A. capital raising by deal type (2014-YTD2018)
Table 9: Total S.A. divestments volume and value trend (2014-YTD2018)
Table 10: Total S.A. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Total S.A. M&A volume and value trend (2014-YTD2018)
Figure 2: Total S.A. M&A activity by geography (2014-YTD2018)
Figure 3: Total S.A. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Total S.A. corporate venturing by geography (2014-YTD2018)
Figure 5: Total S.A. partnership volume and value trend (2014-YTD2018)
Figure 6: Total S.A. partnership trend by key deal type (2014-YTD2018)
Figure 7: Total S.A. capital raising volume and value trend (2014-YTD2018)
Figure 8: Total S.A. capital raising by deal type (2014-YTD2018)
Figure 9: Total S.A. divestments volume and value trend (2014-YTD2018)
Figure 10: Total S.A. divestments by geography (2014-YTD2018)

★海外企業調査レポート[TOTAL S.A.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sime Darby Bhd (SIME):企業の財務・戦略的SWOT分析
    Sime Darby Bhd (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alabama Power Co:企業の戦略的SWOT分析
    Alabama Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AutoNation Inc (AN):企業の財務・戦略的SWOT分析
    AutoNation Inc (AN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Solstad Offshore ASA (SOFF):企業の財務・戦略的SWOT分析
    Summary Solstad Offshore ASA (Solstad) formerly Solstad Farstad ASA is an oil and gas company that provides vessel operation solutions. The company offers carbon footprint, climate neutral network, offshore shipping, green operations, and rainforest protection, documentation programs. It operates th …
  • Ligand Pharmaceuticals Inc (LGND)-製薬・医療分野:企業M&A・提携分析
    Summary Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help in discovery and development of medicines. The company provides a diversified portfolio of biotechnology and pharmaceutical products. Its marketed product portfolio encompasses indication for fungal infections, …
  • Stanford University:企業のM&A・事業提携・投資動向
    Stanford University - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stanford University Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • BiosanaPharma BV:製薬・医療:M&Aディール及び事業提携情報
    Summary BiosanaPharma BV (Biosana) is a biotechnology company engaged in the development of monoclonal antibody biologicals (mAbs), biosimilars and biobetters. Its pipeline products include BP001: biosimilar of Omalizumab (anti-allergy); BP002: biosimilar of Denosumab (anti-osteoporosis); BOX001: or …
  • Numab Innovation AG-製薬・医療分野:企業M&A・提携分析
    Summary Numab Innovation AG (Numab) designs and develops novel therapeutics for the treatment of severe diseases. The company’s lead program ND007, a bispecific antibody fragment which is being evaluated for the treatment of autoimmune diseases. Numab’s other pipeline drug candidates include ND009, …
  • DeepOcean Group Holding BV:企業の戦略的SWOT分析
    DeepOcean Group Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hollard Insurance Group:企業の戦略・SWOT・財務情報
    Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Vectrus Inc (VEC):企業の財務・戦略的SWOT分析
    Vectrus Inc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Epic Pharma LLC-製薬・医療分野:企業M&A・提携分析
    Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug company that develops and manufactures generic prescription drugs. The company’s products include citalopram, betaxolol, amlodipine besylate, meperidine hydrochloride, flacoxate hydrochloride, nicard …
  • Rad Source Technologies Inc:企業の戦略的SWOT分析
    Rad Source Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • W&T Offshore Inc (WTI):石油・ガス:M&Aディール及び事業提携情報
    Summary W&T Offshore Inc (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and offshore in the Gulf of Mexico. The company acquires rights to explore and develop new prospects …
  • Kezar Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kezar Life Sciences Inc (Kezar) is a biotech company that discovers and develops therapies for protein homeostasis. The company’s development program includes KZR-616, a selective small molecule inhibitor of the immunoproteasome. Its KZR-616 finds application in the treatment of autoimmune d …
  • Bowler Metcalf Limited:企業の戦略・SWOT・財務情報
    Bowler Metcalf Limited - Strategy, SWOT and Corporate Finance Report Summary Bowler Metcalf Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tosoh Corp (4042):企業の財務・戦略的SWOT分析
    Tosoh Corp (4042) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Metro Pacific Investments Corporation:企業のM&A・事業提携・投資動向
    Metro Pacific Investments Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Metro Pacific Investments Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Biomedical Structures LLC-医療機器分野:企業M&A・提携分析
    Summary Biomedical Structures LLC (BMS) is a medical device company that designs, develops and manufactures medical textiles. The company manufacturers devices and structures including knitted, braided, woven, non-woven, custom structures, and materials. It offers consulting services such as design …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆